HIV Awal (Early) Testing & Treatment Indonesia Project Observational Phase

Clinical Trial ID NCT03429842

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03429842

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011 69.36
2 Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010 50.17
3 Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2008 36.01
4 Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009 19.90
5 The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011 16.88
6 Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009 14.01
7 Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med 2010 8.72
8 HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med 2012 4.08
9 Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Defic Syndr 2011 3.77
10 Implementation research: what it is and how to do it. BMJ 2013 3.74
11 Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med 2012 3.44
12 Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters. Arch Intern Med 2011 2.99
13 Antiretroviral prophylaxis: a defining moment in HIV control. Lancet 2011 2.17
14 The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission. J Acquir Immune Defic Syndr 2013 1.85
15 Comparative effectiveness of HIV testing and treatment in highly endemic regions. Arch Intern Med 2010 1.41
16 Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure. J Acquir Immune Defic Syndr 2009 1.41
17 Revisiting long-term adherence to highly active antiretroviral therapy in Senegal using latent class analysis. J Acquir Immune Defic Syndr 2011 1.19
18 Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052. Curr Opin HIV AIDS 2012 1.08
19 Treatment as prevention: translating efficacy trial results to population effectiveness. Curr Opin HIV AIDS 2012 1.06
20 Transmitted HIV drug resistance in Asia. Curr Opin HIV AIDS 2013 0.85
21 Modeling the impact of interventions along the HIV continuum of care in Newark, New Jersey. Clin Infect Dis 2013 0.85
22 Treatment-for-prevention: clinical considerations. Curr Opin HIV AIDS 2012 0.84
23 Sharply rising prevalence of HIV infection in Bali: a critical assessment of the surveillance data. Int J STD AIDS 2013 0.78
24 Condom Use Among Men Who Have Sex With Men and Male-to-Female Transgenders in Jakarta, Indonesia. Am J Mens Health 2013 0.77
25 High prevalence of HIV-1 CRF01_AE viruses among female commercial sex workers residing in Surabaya, Indonesia. PLoS One 2013 0.77
Next 100